ATE108063T1 - Heilmittel zur behandlung von toxoplasmose. - Google Patents

Heilmittel zur behandlung von toxoplasmose.

Info

Publication number
ATE108063T1
ATE108063T1 AT89912648T AT89912648T ATE108063T1 AT E108063 T1 ATE108063 T1 AT E108063T1 AT 89912648 T AT89912648 T AT 89912648T AT 89912648 T AT89912648 T AT 89912648T AT E108063 T1 ATE108063 T1 AT E108063T1
Authority
AT
Austria
Prior art keywords
toxoplasmosis
treatment
prophylaxis
animal
remedies
Prior art date
Application number
AT89912648T
Other languages
English (en)
Inventor
Alan Thomas Hudson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE108063T1 publication Critical patent/ATE108063T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT89912648T 1989-09-22 1989-10-26 Heilmittel zur behandlung von toxoplasmose. ATE108063T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898921516A GB8921516D0 (en) 1989-09-22 1989-09-22 Medicaments

Publications (1)

Publication Number Publication Date
ATE108063T1 true ATE108063T1 (de) 1994-07-15

Family

ID=10663513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89912648T ATE108063T1 (de) 1989-09-22 1989-10-26 Heilmittel zur behandlung von toxoplasmose.

Country Status (17)

Country Link
EP (1) EP0445141B1 (de)
JP (1) JP2810746B2 (de)
KR (1) KR920700626A (de)
AT (1) ATE108063T1 (de)
AU (1) AU628422B2 (de)
CA (1) CA2001568C (de)
DE (1) DE68916651T2 (de)
DK (1) DK175716B1 (de)
GB (1) GB8921516D0 (de)
HU (1) HU207942B (de)
IE (1) IE66153B1 (de)
MC (1) MC2142A1 (de)
MW (1) MW1291A1 (de)
PH (1) PH27250A (de)
SG (1) SG28346G (de)
WO (1) WO1991004021A1 (de)
ZA (1) ZA898146B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
WO2010023686A2 (en) * 2008-08-29 2010-03-04 Matrix Laboratories Limited Crystalline form of 2-chloro-3-[4-(4-chlorophenyl) cyclohexyl] [1,4]naphthoquinone, process for the same and use for producing 2-[4-(4-chlorophenyl)cyclohexyl]-3- hydroxy- 1,4- naphthoquinone
WO2013093937A2 (en) * 2011-09-16 2013-06-27 Alkem Laboratories Ltd. ''3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2- trans-[(4-chloro phenyl) cyclohexyl] [1,4]naphthaquinone"-atovaquone prodrug
CN104474416A (zh) * 2014-11-03 2015-04-01 青岛绿曼生物工程有限公司 治疗猪弓形体病的复方蜂胶组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
DE68928964T2 (de) * 1988-08-16 1999-07-29 Wellcome Found Neue Naphthochinone und ihre Anwendung als Arzneimittel

Also Published As

Publication number Publication date
IE893451A1 (en) 1991-03-27
DK93091A (da) 1991-06-28
DK93091D0 (da) 1991-05-16
HU896916D0 (en) 1991-08-28
DK175716B1 (da) 2005-01-31
CA2001568A1 (en) 1991-03-22
PH27250A (en) 1993-05-04
HU207942B (en) 1993-07-28
EP0445141B1 (de) 1994-07-06
AU628422B2 (en) 1992-09-17
AU4519189A (en) 1991-04-18
HUT57040A (en) 1991-11-28
WO1991004021A1 (en) 1991-04-04
DE68916651T2 (de) 1995-02-16
ZA898146B (en) 1991-06-26
DE68916651D1 (de) 1994-08-11
KR920700626A (ko) 1992-08-10
MW1291A1 (en) 1991-11-13
GB8921516D0 (en) 1989-11-08
CA2001568C (en) 1998-05-12
IE66153B1 (en) 1995-12-13
EP0445141A1 (de) 1991-09-11
MC2142A1 (fr) 1992-02-18
JP2810746B2 (ja) 1998-10-15
SG28346G (en) 1995-09-18
JPH04504107A (ja) 1992-07-23

Similar Documents

Publication Publication Date Title
DE69602412D1 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
ATE108063T1 (de) Heilmittel zur behandlung von toxoplasmose.
DE69125940D1 (de) Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
DE68916443D1 (de) Arzneimittel zur behandlung von kryptosporidiose.
DE69312297T2 (de) Verwendung von 2-[4-(-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinon zur behandlung von krebs
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
HUT62474A (en) Process for producing veterinary composition with antiparasitic effect
RU2011380C1 (ru) Способ профилактики и лечения некробактериоза животных
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
BR0016427A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time